EP0093851A3 - Fatty acid carriers for synthetic vaccines - Google Patents

Fatty acid carriers for synthetic vaccines Download PDF

Info

Publication number
EP0093851A3
EP0093851A3 EP83102392A EP83102392A EP0093851A3 EP 0093851 A3 EP0093851 A3 EP 0093851A3 EP 83102392 A EP83102392 A EP 83102392A EP 83102392 A EP83102392 A EP 83102392A EP 0093851 A3 EP0093851 A3 EP 0093851A3
Authority
EP
European Patent Office
Prior art keywords
fatty acid
acid carriers
synthetic vaccines
vaccines
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP83102392A
Other languages
English (en)
Other versions
EP0093851A2 (en
Inventor
Thomas Patrick Hopp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of EP0093851A2 publication Critical patent/EP0093851A2/en
Publication of EP0093851A3 publication Critical patent/EP0093851A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP83102392A 1982-03-15 1983-03-11 Fatty acid carriers for synthetic vaccines Ceased EP0093851A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35815082A 1982-03-15 1982-03-15
US358150 1982-03-15

Publications (2)

Publication Number Publication Date
EP0093851A2 EP0093851A2 (en) 1983-11-16
EP0093851A3 true EP0093851A3 (en) 1985-04-10

Family

ID=23408497

Family Applications (1)

Application Number Title Priority Date Filing Date
EP83102392A Ceased EP0093851A3 (en) 1982-03-15 1983-03-11 Fatty acid carriers for synthetic vaccines

Country Status (4)

Country Link
EP (1) EP0093851A3 (ja)
JP (1) JPH07116055B2 (ja)
CA (1) CA1231094A (ja)
ZA (1) ZA831547B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5837249A (en) * 1985-04-19 1998-11-17 The Wistar Institute Method for generating an immunogenic T cell response protective against a virus
US5871746A (en) * 1990-12-18 1999-02-16 Institut National De La Sainte Et De La Recherche Medicale (Inserm) Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
FR2670787B1 (fr) * 1990-12-18 1995-06-23 Pasteur Institut Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
JP2004533421A (ja) 2001-03-27 2004-11-04 バイオミラ，インコーポレイテッド Ｔ１免疫応答とｔ２免疫応答との間で調節するためのワクチン
TWI395591B (zh) 2004-04-01 2013-05-11 Oncothyreon Inc 黏液性糖蛋白（ｍｕｃ-１）疫苗
CA2613327A1 (en) 2005-06-28 2007-02-08 Biomira, Inc. Method of treating patients with a mucinous glycoprotein (muc-1) vaccine
MX2013009742A (es) 2011-02-24 2014-01-31 Oncothyreon Inc Vacuna de glicolipopeptidos a base de muc1 con adyuvante.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349569A1 (fr) * 1976-04-29 1977-11-25 Bonnierfoeretagen Ab Polypeptide synthetique ayant une activite antigenique et sa preparation
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
EP0056249A2 (en) * 1981-01-09 1982-07-21 New York Blood Center, Inc. Synthetic antigenic composition and process for making same
WO1982004250A1 (en) * 1981-05-26 1982-12-09 Northwestern Univ Antigenic linear peptide compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349569A1 (fr) * 1976-04-29 1977-11-25 Bonnierfoeretagen Ab Polypeptide synthetique ayant une activite antigenique et sa preparation
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
EP0056249A2 (en) * 1981-01-09 1982-07-21 New York Blood Center, Inc. Synthetic antigenic composition and process for making same
WO1982004250A1 (en) * 1981-05-26 1982-12-09 Northwestern Univ Antigenic linear peptide compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. USA, vol. 79, no. 14, July 1982, pages 4400-4404, Immunology; P.K. BHATNAGAR et al.: "Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant" *
PROC. NATL. ACAD. SCI. USA, vol. 79, no. 2, January 1982, pages 579-582, Immunology; A.M. PRINCE et al.: "Hepatitis B virus vaccine: Identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide" *

Also Published As

Publication number Publication date
CA1231094A (en) 1988-01-05
JPS58222031A (ja) 1983-12-23
EP0093851A2 (en) 1983-11-16
JPH07116055B2 (ja) 1995-12-13
ZA831547B (en) 1984-10-31

Similar Documents

Publication Publication Date Title
GB8326029D0 (en) Esters
DE3361480D1 (en) Difluoromethoxyphenylthiophosphoric-acid esters
GB8313202D0 (en) Carrier
GB8520479D0 (en) Crystalline esters
GB8403347D0 (en) Amidealkanesulfonic acids
ZA831547B (en) Fatty acid carriers for synthetic vaccines
GB8334070D0 (en) Isolating l-amino acids
GB8318335D0 (en) Tetrafluoroterephthalyl alcohol
CS266283A1 (en) Vicefunkcni fermentor
GB2126234B (en) Novel vitamin d analogs
MY8700194A (en) Carbamic-acid esters
GB8328747D0 (en) Aminocyclopentane acids
GB2134080B (en) Cargo carriers
IL67012A0 (en) Ejector
ZA873231B (en) Synthetic fatty acid process
GB8320494D0 (en) Aminolactonecarboxylic acid
GB8510717D0 (en) Ester
IL69037A0 (en) Benzoylparabanic acids
GB2129284B (en) Trays
YU267782A (en) Eggs carrier
GB2114964B (en) Boric acid
GB2132191B (en) Beta-disubstituted monocarboxylic acids
GB8323276D0 (en) 3-acylamino-2-oxo-1-azetidinyl esters
GB8310691D0 (en) Hydroxymethylbutenoic acids
GB8328516D0 (en) Preparing perfluoroacrylic acid ester

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19850621

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOPP, THOMAS PATRICK

Inventor name: WOODS, KENNETH R., DR.

17Q First examination report despatched

Effective date: 19870430

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOPP, THOMAS PATRICK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19890911

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOPP, THOMAS PATRICK